$GERN
GERON CORP

2017 Q3 Form 10-Q Financial Statement

#000156459017020773 Filed on November 01, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $163.0K $5.108M
YoY Change -96.81% -85.55%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.770M $4.670M
YoY Change 2.14% 7.85%
% of Gross Profit
Research & Development $2.640M $4.319M
YoY Change -38.87% 6.64%
% of Gross Profit
Depreciation & Amortization $20.00K $20.00K
YoY Change 0.0% 0.0%
% of Gross Profit
Operating Expenses $7.407M $8.985M
YoY Change -17.56% 7.22%
Operating Profit -$7.244M -$3.877M
YoY Change 86.85%
Interest Expense $350.0K $300.0K
YoY Change 16.67% 76.47%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.900M -$3.580M
YoY Change 92.74% -113.17%
Income Tax
% Of Pretax Income
Net Earnings -$6.899M -$3.576M
YoY Change 92.93% -113.15%
Net Earnings / Revenue -4232.52% -70.01%
Basic Earnings Per Share
Diluted Earnings Per Share -$43.34K -$22.50K
COMMON SHARES
Basic Shares Outstanding 159.1M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $96.90M $108.5M
YoY Change -10.69% -9.36%
Cash & Equivalents $10.17M $5.883M
Short-Term Investments $87.00M $102.7M
Other Short-Term Assets $1.200M $1.100M
YoY Change 9.09% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $98.60M $115.1M
YoY Change -14.34% -5.66%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $200.0K
YoY Change -50.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $15.60M $21.00M
YoY Change -25.71% -33.96%
Other Assets
YoY Change
Total Long-Term Assets $15.64M $21.10M
YoY Change -25.86% -34.06%
TOTAL ASSETS
Total Short-Term Assets $98.60M $115.1M
Total Long-Term Assets $15.64M $21.10M
Total Assets $114.2M $136.2M
YoY Change -16.12% -11.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $261.0K $300.0K
YoY Change -13.0% -50.0%
Accrued Expenses $1.112M $7.000M
YoY Change -84.11% 25.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.970M $7.300M
YoY Change -18.22% 19.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.970M $7.300M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.000M $7.300M
YoY Change -17.81% 19.67%
SHAREHOLDERS EQUITY
Retained Earnings -$978.4M
YoY Change
Common Stock $1.087B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $108.3M $128.9M
YoY Change
Total Liabilities & Shareholders Equity $114.2M $136.2M
YoY Change -16.12% -11.56%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$6.899M -$3.576M
YoY Change 92.93% -113.15%
Depreciation, Depletion And Amortization $20.00K $20.00K
YoY Change 0.0% 0.0%
Cash From Operating Activities -$4.420M -$6.560M
YoY Change -32.62% 33.6%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $7.730M $4.150M
YoY Change 86.27% -28.08%
Cash From Investing Activities $7.730M $4.150M
YoY Change 86.27% -27.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 90.00K
YoY Change -100.0% -57.14%
NET CHANGE
Cash From Operating Activities -4.420M -6.560M
Cash From Investing Activities 7.730M 4.150M
Cash From Financing Activities 0.000 90.00K
Net Change In Cash 3.310M -2.320M
YoY Change -242.67% -327.45%
FREE CASH FLOW
Cash From Operating Activities -$4.420M -$6.560M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$4.420M -$6.560M
YoY Change -32.62% 34.98%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13833000
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
7407000
us-gaap Operating Expenses
OperatingExpenses
27933000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21865000
us-gaap Interest And Other Income
InterestAndOtherIncome
871000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
13927000
gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
6068000
CY2016Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4319000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
8510000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4666000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14006000
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
8985000
us-gaap Operating Expenses
OperatingExpenses
22343000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3877000
us-gaap Operating Income Loss
OperatingIncomeLoss
-21469000
CY2016Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
322000
us-gaap Interest And Other Income
InterestAndOtherIncome
1041000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
61000
us-gaap Net Income Loss
NetIncomeLoss
-21055000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159011741
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
238000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20817000
CY2017Q3 gern Collaborative Arrangement Accrued Collaboration Charges Current
CollaborativeArrangementAccruedCollaborationChargesCurrent
1946000
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2651000
CY2017Q3 us-gaap Assets
Assets
114244000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
261000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1112000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1434000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5970000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
159000
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1086578000
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-978411000
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-52000
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
108274000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
114244000
CY2017Q3 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
163000
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4770000
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7244000
CY2017Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
363000
CY2017Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
18000
CY2016Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
21000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
59000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-6899000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3576000
us-gaap Net Income Loss
NetIncomeLoss
-20487000
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159216642
CY2016Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159140254
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159186853
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6872000
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3641000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20486000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
57000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
63000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
16000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-213000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-507000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
159000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
123000
us-gaap Share Based Compensation
ShareBasedCompensation
6152000
us-gaap Share Based Compensation
ShareBasedCompensation
6263000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32000
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
60000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
401000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4397000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-1899000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
16000
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
685000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16169000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17767000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
81260000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
105698000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
94486000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
106954000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
13226000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1245000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
37000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1157000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
37000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1157000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2906000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15365000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21248000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5883000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities, income taxes, and stock-based compensation. Management bases its estimates on historical experience and on various other market specific and relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div>
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
116042000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
54000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
107000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
115989000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14897936
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11536380
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14354172
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11298948
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P4Y
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2094000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2127000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6152000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6263000
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
102603000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
80000
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
102551000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
64356000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
66534000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
52000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
97000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
11475000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
6944000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
28000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
10000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
75831000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
73478000
CY2017Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
80000
CY2016Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
107000
CY2017Q3 gern Trading Restriction Period
TradingRestrictionPeriod
P24M
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1380000

Files In Submission

Name View Source Status
0001564590-17-020773-index-headers.html Edgar Link pending
0001564590-17-020773-index.html Edgar Link pending
0001564590-17-020773.txt Edgar Link pending
0001564590-17-020773-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gern-10q_20170930.htm Edgar Link pending
gern-20170930.xml Edgar Link completed
gern-20170930.xsd Edgar Link pending
gern-20170930_cal.xml Edgar Link unprocessable
gern-20170930_def.xml Edgar Link unprocessable
gern-20170930_lab.xml Edgar Link unprocessable
gern-20170930_pre.xml Edgar Link unprocessable
gern-ex311_9.htm Edgar Link pending
gern-ex312_8.htm Edgar Link pending
gern-ex321_7.htm Edgar Link pending
gern-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending